RheumaFinder is thrilled to announce a significant achievement for our co-founder, Thomas Van Den Berghe, who successfully defended his PhD at the Ghent University and Ghent University Hospital on Radiomics, Radiogenomics, and Artificial Intelligence in Musculoskeletal Radiology last week. This accomplishment not only marks a personal milestone for Thomas but also highlights the innovative spirit of the RheumaFinder team.
In his research at Ghent University and Ghent University Hospital, Thomas explored the critical role of artificial intelligence in enhancing the diagnosis and therapy response monitoring of bone tumors and early detection of rheumatic diseases. By developing advanced algorithms, the Ghent University, Ghent University Hospital and RheumaFinder team aims to address the widespread challenge of late diagnosis, ultimately leading to improved patient outcomes. This focus on practical applications of AI in musculoskeletal radiology aligns perfectly with RheumaFinder’s mission to transform academic research, at present developed at the Ghent University and Ghent University Hospital, into real-world solutions.
We are proud to be at the forefront of this innovation, leveraging Thomas’s research to revolutionize the field of musculoskeletal oncology and rheumatology. As we continue down this path, we invite you to stay tuned for more updates on our progress and the exciting developments to come!
This post was also published on our LinkedIn page.